NCT02014350

Unknown

Outcomes Following Delta Xtend Reverse Shoulder System

Rothman Institute Orthopaedics Source

Other study identifiers

Sponsor study identifier

RI2013

Study Type

observational

Reported enrollment (type unavailable)

N/A

Locations

1 country

Sites

1

Timeline

Study Start

Not reported

Date not reported

Primary Completion

March 2020

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

Not reported

Date not reported

Brief Summary

To collect medium to long-term survivorship implant outcomes on the DePuy Delta Xtend Reverse Shoulder Stystem.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: unknown
Reported enrollment (type unavailable): Not reported
Study completion date: Not reported
Date not reported
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
December 12, 2013
Actual (reported)
First Posted
December 18, 2013
Actual (reported)
Primary Completion
March 2020
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated: December 18, 2013
Status Verified: December 2013
Last Update Submitted: December 17, 2013

Conditions

Reverse Total Shoulder Arthroplasty

Outcome Measures

Primary Outcomes (1)

Implant Survivorship
10 years post-operative

Study Arms (1)

DePuy Delta Xtend RTSA

Device: DePuy Delta Xtend Reverse TSA

Interventions

DePuy Delta Xtend Reverse TSADevice

DePuy Delta Xtend RTSA

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodProbability Sample

Study Population

patients who were implanted with the DePuy Delta Xtend Reverse Total Shoulder Arthoplasty between 2008-2012

You may qualify if:

Patients whom were implanted with the DePuy Delta Xtend Reverse Total Shoulder System in the time frame indicated. Patients must be willing to sign the consent form and complete all follow-up visits.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Rothman Institute Orthopaedics
Otherlead

Study Sites (1)

Rothman Institute

Philadelphia, Pennsylvania, 19107, United States

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: CROSS SECTIONAL
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

December 12, 2013

First Posted

December 18, 2013

Primary Completion

March 2020

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated

December 18, 2013

NCT06133920

Duration of Immobilization After Reverse Total Arthroplasty for Proximal Humerus Fractures

Recruiting

NCT06891378

At Home, Digital Rehabilitation for Patients After Reverse Total Shoulder Arthroplasty

Not ApplicableRecruiting

NCT06292169

Pectoralis Minor Release Versus Non-release in RSA

Not ApplicableRecruiting

NCT06733480

Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue

Not ApplicableRecruiting

NCT02052466

Prediction of Development of Scapular Notching Following Reverse Total Shoulder Arthroplasty

Completed

NCT02569658

Investigation of Intravenous Tranexamic Acid With Anatomic and Reverse Total Shoulder Arthroplasty

Not ApplicableCompleted

Record last verified: 2013-12

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT02014350
Data provider: ClinicalTrials.gov
Source updated: 2013-12-18
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:27:16 UTC

Locations

US(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Primary Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

DePuy Delta Xtend RTSA

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Study Design

Study Record Dates

Source record

Locations